Clinical trial
Behavioral Intervention Trial for HIV-infected Injection Drug Users
NCT00146445 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00146445 |
|---|---|
| Title | Behavioral Intervention Trial for HIV-infected Injection Drug Users |
| Official title | Intervention for Seropositive Injection Drug Users - Research and Evaluation (INSPIRE) |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Health Services Resource Adminstration - HIV/AIDS Bureau |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Behavioral |
| Interventions | Peer Mentoring Intervention |
| Enrollment | 1,000 |
| Start date | Aug 1, 2001 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 7, 2005 |
| Last update posted | Sep 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: